Waiting
Processando Login

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Perfil de la sensibilidad a las terapias…
JoVE Journal
Cancer Research

Este de .

JoVE Journal Cancer Research
Perfil de la sensibilidad a las terapias dirigidas en organoides derivados de pacientes con NSCLC con mutación de EGFR
An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
Journal (Cancer Research)
An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
Measuring Real-time Drug Response in Organotypic Tumor Tissue Slices
Journal (Cancer Research)
Measuring Real-time Drug Response in Organotypic Tumor Tissue Slices
 
Click here for the English version

Perfil de la sensibilidad a las terapias dirigidas en organoides derivados de pacientes con NSCLC con mutación de EGFR

Article DOI: 10.3791/63039-v • 08:52 min • November 22nd, 2021
November 22nd, 2021 •
1,2,3, 1,2, 1,2,3, 1,2,3
1Department of Medicine, University of California, San Francisco, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 3Department of Cellular and Molecular Pharmacology, University of California, San Francisco

Capítulos

Resumo
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Este protocolo describe una evaluación estandarizada de las sensibilidades de los medicamentos a los inhibidores de señalización dirigidos en modelos organoides derivados de pacientes con NSCLC.

Tags

Cancer Research Número 177 Organoide organoide pulmonar DOP NSCLC cáncer de pulmón osimertinib EGFR inhibidor dirigido resistencia
Read Article
Waiting X
Simple Hit Counter